Neurology 1607 - Neurology Alert - Jul 01, 2012

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology and Neuroscience;
Specialty area, Movement Disorders

John J. Caronna, MD
Professor of Clinical Neurology;
Specialty area, Stroke and General Neurology

Authors

Michael Lin, MD, PhD
Associate Professor of Neurology and Neurosciences
Weill Cornell Medical College

Douglas Labar, MD, PhD
Professor of Neurology and Neruoscience
Weill Cornell Medical College

Subjects:

  • Primary Progressive Apraxia of Speech: A Distinct Disorder
  • New Therapies for Tinnitus
  • Predicting Response to IVIG or Plasmapheresis in Myasthenia Gravis
  • An Advance in the Search for Parkinson's Disease Biomarkers
  • Outcome of Shunting for Idiopathic 'Normal Pressure Hydrocephalus'
  • Stroke Alert: A Review of Current Clinical Stroke Literature

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors Michael Rubin, MD, FRCP(C), author Michael Lin, MD, PhD, author Douglas Labar, MD, PhD, author John J. Caronna, MD, peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2012 AHC Media LLC. All rights reserved.